Approximately 5% of ovarian cancer cases can be attributed to an autosomal
dominant inheritance factor. The majority of these cases are due to germlin
e mutations in the BRCA1 or BRCA2 tumoursupressor genes. Patients with here
ditary disease do not exhibit pathognomonic features that would allow disti
nction from non-hereditary (sporadic) cases of ovarian cancer. Our studies
are aimed at identifying clinical, histopathological as well as molecular g
enetic differences between hereditary and sporadic ovarian cancer. Clinical
studies of the ovarian cancer cases in 31 families revealed differences re
garding age at onset and stage as well as in survival compared with cancer
registry controls. The molecular studies of hereditary ovarian cancer are s
till underway and some preliminary data is discussed. (C) 1999 Published by
Elsevier Science Ireland Ltd. All rights reserved.